Company Overview and News

 
Subaru finds more improper vehicle inspections, blames high workloads

2018-09-29 japantimes.co.jp
Subaru Corp. has revealed fresh cases of improper final vehicle inspections in a final report on its data falsifications, blaming inspectors’ excessive workloads.
5406 KBSTF KBSTY 5711 MIMTF

 
Nissan reports preventive steps to government in wake of data fabrication scandal

2018-09-26 japantimes.co.jp
Nissan Motor Co. submitted a report to the government Wednesday containing measures to prevent any further fabrication of exhaust emissions and fuel efficiency data.
5406 KBSTF KBSTY 5711 MIMTF

 
Shinzo Abe: Shrewd diplomat in for the long haul

2018-09-20 bworldonline
SHINZO Abe comes from a long line of politicians but the hawkish nationalist is now poised to write his name into the record books as Japan’s longest-serving premier.
5406 KBSTF KBSTY

 
Japan’s Kubota admits falsifying data for metal components

2018-09-12 japantimes.co.jp
Tractor-maker Kubota Corp. said Wednesday it had falsified data for metal rolling components, joining other Japanese manufacturers that have admitted in the past year to faulty inspections or data manipulation.
5406 KBSTF KBSTY

 
Three Mitsubishi Materials units indicted over data fabrication

2018-09-12 japantimes.co.jp
Tokyo prosecutors said Wednesday they have indicted three subsidiaries of Mitsubishi Materials Corp. and the former presidents at two of the units over suspected product data fabrication.
5406 KBSTF KBSTY 5711 MIMTF

 
Asia Markets: Asian markets fall as Trump pushes more tariffs against China

2018-08-31 marketwatch
Asian stocks were broadly lower in early trading Friday, after a report that President Donald Trump was pushing ahead with his plan for tariffs on an additional $200 billion worth of Chinese goods and threatened to withdraw the U.S. from the World Trade Organization.
5406 KBSTF KBSTY

 
Asia Markets: Asian markets jump out to strong gains to start the week

2018-08-27 marketwatch
Asian stock markets posted nearly across-the-board gains in early trading Monday, with South Korea the lone holdout.
5406 KBSTF KBSTY 5482

 
Japan ministries may have fiddled numbers of disabled employees: media

2018-08-17 theedgemarkets
TOKYO (Aug 17): Several ministries in Japan may have been inflating for decades the number of disabled people they employ in order to meet quotas, media said on Friday, even as the government imposes levies on private companies that fail to meet theirs.
5406 KBSTF KBSTY

 
Report: Japan ministries may have fiddled numbers of disabled employees

2018-08-17 malaymail
TOKYO, Aug 17 — Several ministries in Japan may have been inflating for decades the number of disabled people they employ in order to meet quotas, media said today, even as the government imposes levies on private companies that fail to meet theirs.
5406 KBSTF KBSTY

 
Japan ministries may have inflated numbers of disabled employees, media say

2018-08-17 channelnewsasia
TOKYO: Several ministries in Japan may have inflated their numbers of disabled employees for more than four decades, media said on Friday, while companies that miss quotas set by law face fines.
5406 KBSTF KBSTY

 
Nikkei edges down to 22,192 on receding U.S.-China trade worries

2018-08-16 japantimes.co.jp
The key Nikkei average closed marginally lower Thursday after cutting most of its early loss thanks to receding worries about U.S.-China trade friction.
5406 KBSTF KBSTY MRAAF MRAAY

 
Mazda, Suzuki, Yamaha Motor apologize for improper vehicle tests

2018-08-09 channelnewsasia
Mazda Motor Corp , Suzuki Motor Corp and Yamaha Motor Co conducted improper fuel economy and emissions tests on their vehicles, Japan's transport ministry said on Thursday.
7261 KBSTF MZDAY MIMTF TRYIF 5406 VLKAF KBSTY 3402 5711 MZDAF 7269 TRYIY

 
Ministry reveals Suzuki, Mazda, Yamaha Motor conducted improper fuel economy, emissions tests on vehicles

2018-08-09 japantimes.co.jp
Mazda Motor Corp., Suzuki Motor Corp. and Yamaha Motor Co. conducted improper fuel economy and emissions tests on their vehicles, the transport ministry said Thursday.
5406 7261 KBSTF MZDAY KBSTY 5711 MZDAF 7269 MIMTF

 
Japan says Mazda, Suzuki, Yamaha Motor carried out improper testing

2018-08-09 channelnewsasia
Mazda Motor Corp , Suzuki Motor Corp and Yamaha Motor Co conducted improper fuel economy and emissions tests on their vehicles, Japan's transport ministry said on Thursday.
5406 7261 KBSTF MZDAY KBSTY 3402 5711 MZDAF 7269 MIMTF TRYIY TRYIF

2
Nikkei edges down on weak earnings

2018-08-02 thehindubusinessline
Kobe Steel fell more than 8 per cent after it reported a 55 per cent drop in recurring profit in the April-June quarter as a data-tampering scandal that hit Japan's third largest steelmaker hurt profits.
MZHOF KBSTF ADTTF SMFG KNCAY SMFNF TOELY 5406 SUOPY 4902 KBSTY 8316 8306 MUFG 8411 SUMCF TOELF 8035 KNCAF MBFJF ATEYY MTU MFG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 006496023